Navigation Links
MRI with nanoparticles highly sensitive in detecting prostate cancer metastases

High-resolution MRI with magnetic nanoparticles is highly sensitive in detecting clinically occult lymph-node metastases in prostate cancer, according to a new report. In fact, routine use of this modality preoperatively could obviate many unneeded surgeries.//
The nanoparticles, which are given intravenously 24 hours before scanning, work by binding to lymphatic cells. The particles only bind to normal cells, so it is the areas that do not "light up" on MRI that are suspicious for malignancy.

MRI with magnetic nanoparticles "is very likely going to change the way cancers can be staged," say senior doctors. "In the study 25% of patients could have avoided surgery if scanning with nanoparticles had been done preoperatively." Currently, there is no way of knowing before surgery which patients will have microscopic tumor spread to the lymph nodes.

The findings, which are published in the June 19th issue of The New England Journal of Medicine, are based on a study of 80 men with prostate cancer who underwent lymph-node resection or biopsy. Prior to surgery, MRI was performed in all patients before and after infusion of nanoparticles. Of the 334 nodes removed, 63 had histologically proven metastases. With standard imaging criteria for malignancy, 45 of these nodes would have been falsely considered disease free.

MRI with nanoparticles correctly identified all of the patients with nodal disease. In addition, on node-by-node analysis, the sensitivity of this modality, at 90.5%, was significantly higher than that of conventional MRI, at 35.4% (p < 0.001). The nanoparticles appear to be very safe and none of the patients experienced any side effects so far.

The team has also tested the agent's ability to detect metastases from lung and breast cancer and it appears to work equally well. "That's the beauty of targeting normal cells rather than focusing on the malignant cells which always mutate ."

The nanoparticl es, which are being developed by Massachusetts-based Advanced Magnetics Inc. under the name Combidex, are in the final stages of approval by the US Food and Drug Administration.
'"/>




Related medicine news :

1. Threat posed by highly resistant strains of TB
2. Female Circumcision highly Prevalent in Mali
3. Sensitive to bright light? You may have sensitive teeth also
4. Some more sensitive to pain
5. Adult stem cells are sensitive to responses from the environment
6. HIV Positive Individuals Say Media Is Insensitive
7. Vitamin B12 can help in detecting cancers
8. New device for detecting artery blockages
9. Associated scan for detecting ovarian cancer spread
10. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
11. Measuring disseminated cancer cells in bone marrow - valuable tool for detecting early breast cancer metastasis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... , ... September 26, 2017 , ... “Sonflower Submission”: ... strong-willed nature to the inevitable destinations of negativity, complaining and the need to always ... to take effect in order for a lesson in stress-less living to be learned. ...
(Date:9/26/2017)... ... September 26, 2017 , ... “The Great Creator Saves Boobie and Ceebie”: a tool families ... Boobie and Ceebie” is the creation of published author, G.S. White, a devoted follower of ... in New Jersey. , “This book is not only for children but also to ...
(Date:9/25/2017)... ... September 25, 2017 , ... SignatureCare Emergency Center ... $1000 student scholarship is awarded each semester to a deserving student. Congratulations Ashlea! ... is a medical student at Arizona State University with a 3.63 GPA. Grabau ...
(Date:9/25/2017)... ... ... The Renal Support Network (RSN) is proud to announce the launch of ... focused on RSN’s mission to empower people who have kidney disease to become knowledgeable ... Our unique website is loaded with hundreds of exclusive personal stories. These posts are ...
(Date:9/25/2017)... ... 25, 2017 , ... FDAnews Expert Insight Series:, Device Regulation ... – 3:00 p.m. ET, http://www.fdanews.com/deviceregulation      , FDA Commissioner Scott ... short months:, ,     The first device recall over cybersecurity (a ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 8, 2017 ... Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 th .The ... free MRI brain scans to the public.Where:  BTF,s ... at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly and ... actions to streamline operations to more efficiently focus ... its cost structure. Global workforce reductions, including those ... expected to impact approximately 3,500 positions. ... expects annualized savings of approximately $500 million that ...
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir ... Smart Spirometer, announced today a partnership with Novartis Pharma AG ... solidifies NuvoAir,s position as the leading mobile spirometry platform and ... patients. ... test ...
Breaking Medicine Technology: